Over a year on and after a bit of balancing, I feel amazing
Yes, oral semaglutide is a prescription GLP-1 receptor agonist approved for type 2 diabetes
doi:10.1056/NEJMoa2206038 Wilding JPH, Batterham RL, Calanna S, et al
Although some studies found a positive relationship between antioxidant supplementation and risk reduction, others have not found such positive effects
Prokinetic drugs, such as cisapride, stimulate smooth muscle, but since most of the esophagus is skeletal muscle, the efficacy of such drugs is questionable for treatment of megaesophagus
A 2026 Washington University School of Medicine analysis of veterans with type 2 diabetes found that even brief interruptions of GLP-1 treatment -- as little as six months -- were associated with higher risk of heart attack, stroke, and death compared with continuous use